PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-27.40%
Negative revenue growth while 6617.T stands at 30.29%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-30.39%
Negative gross profit growth while 6617.T is at 38.53%. Joel Greenblatt would examine cost competitiveness or demand decline.
-146.88%
Negative EBIT growth while 6617.T is at 155.58%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-162.90%
Negative operating income growth while 6617.T is at 173.84%. Joel Greenblatt would press for urgent turnaround measures.
-180.00%
Negative net income growth while 6617.T stands at 155.05%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-180.00%
Negative EPS growth while 6617.T is at 155.74%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-180.00%
Negative diluted EPS growth while 6617.T is at 155.74%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.59%
OCF growth above 1.5x 6617.T's 3.33%. David Dodd would confirm a clear edge in underlying cash generation.
9.59%
FCF growth above 1.5x 6617.T's 3.33%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-30.52%
Negative 10Y revenue/share CAGR while 6617.T stands at 35.58%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-6.70%
Negative 5Y CAGR while 6617.T stands at 27.72%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
1.86%
3Y revenue/share CAGR under 50% of 6617.T's 19.07%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-147.74%
Negative 10Y net income/share CAGR while 6617.T is at 604.66%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-1678.92%
Negative 5Y net income/share CAGR while 6617.T is 436.62%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-56.19%
Negative 3Y CAGR while 6617.T is 85.81%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
101.72%
10Y equity/share CAGR above 1.5x 6617.T's 23.25%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
48.01%
5Y equity/share CAGR above 1.5x 6617.T's 20.09%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
31.40%
3Y equity/share CAGR above 1.5x 6617.T's 18.13%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
12.82%
AR growth well above 6617.T's 18.33%. Michael Burry fears inflated revenue or higher default risk in the near future.
19.48%
Inventory growth well above 6617.T's 1.46%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
13.51%
Asset growth above 1.5x 6617.T's 6.24%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-0.62%
We have a declining book value while 6617.T shows 3.23%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
32.76%
Debt shrinking faster vs. 6617.T's 88.93%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
42.86%
We increase R&D while 6617.T cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-0.46%
We cut SG&A while 6617.T invests at 6.91%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.